Pfizer Inc.

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2025-12-12 pm EST			Pre-market 07:22:13 am
25.85 ^USD	+0.19%		25.92	+0.25%

Dec. 12	US FDA approves Innoviva's oral antibiotic for gonorrhea	RE
Dec. 12	Pfizer Inc. Declares First-Quarter 2026 Dividend, Payable on March 6, 2026	CI

Pfizer Reportedly to Sell $3.05 Billion Worth of Haleon Shares

Published on 01/15/2025 at 06:35 am EST - Modified on 01/15/2025 at 06:40 am EST

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Pfizer Inc.

Dec. 12	US FDA approves Innoviva's oral antibiotic for gonorrhea	RE
Dec. 12	Pfizer Inc. Declares First-Quarter 2026 Dividend, Payable on March 6, 2026	CI
Dec. 12	Rate Cuts Can't Buy Confidence
Dec. 12	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
Dec. 12	Health Rounds: Pfizer drug delays progression of advanced breast cancer in trial	RE
Dec. 12	US FDA Considering 'Black Box' Warning for COVID-19 Vaccines	MT
Dec. 12	Morgan Stanley Adjusts Price Target on Pfizer to $28 From $32, Maintains Equalweight Rating	MT
Dec. 12	GSK gets EU regulator backing for expanded use of RSV vaccine	RE
Dec. 11	US FDA expands use of GSK's Blujepa as treatment for gonorrhea	RE
Dec. 11	Sector Update: Health Care Stocks Mixed Premarket Thursday	MT
Dec. 11	Roivant Highlights Continued Pipeline Progress and Outlook for Company's Next Phase of Growth At 2025 Investor Day	CI
Dec. 11	IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (Optimum-02) of Darovasertib in Combination with Crizotinib in First-Line HLA A2-Negative Metastatic Uveal Melanoma	CI
Dec. 11	IDEAYA Biosciences Completes Targeted Full Enrollment in Trial of Darovasertib With Pfizer's Crizotinib	MT
Dec. 11	C.Q. Pharmaceutical's Unit Grants Pfizer Rights Over Peptide-1 Products	MT
Dec. 11	Pfizer Plans Workforce Reduction in Switzerland	MT
Dec. 10	Elevance Health Announces Appointment of Amy Schulman as Independent Director, Effective January 12, 2026	CI
Dec. 10	Nuvalent, Inc. Announces Board Changes	CI
Dec. 10	Sector Update: Health Care Stocks Climb Late Afternoon	MT
Dec. 10	Sector Update: Health Care Stocks Advance in Afternoon Trading	MT
Dec. 10	Sector Update: Health Care	MT
Dec. 10	Pfizer to Cut More Than 200 Jobs in Switzerland	MT
Dec. 10	Pfizer to cut over 200 jobs in Switzerland to reduce costs, Bloomberg News reports	RE
Dec. 10	Pfizer to cut hundreds of jobs in Switzerland to reduce costs, Bloomberg News reports	RE
Dec. 10	Pfizer is cutting hundreds of jobs in Switzerland to lower costs - Bloomberg News	RE
Dec. 10	Pfizer Says Metatstatic Breast Cancer Treatment Extends Median Progression-Free Survival	MT

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.

Employees

81,000

Sector

Pharmaceuticals

Calendar

Dec. 16 - Q4 2026 Guidance Call

More about the company